Day: June 22, 2022

Rhythm Pharmaceuticals Launches IMCIVREE® (setmelanotide) in Germany for the Treatment of Obesity and Control of Hunger Associated with POMC or LEPR Deficiency

Written by Customer Service on June 22, 2022. Posted in Public Companies.

BOSTON, June 22, 2022 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the care of people living with rare genetic diseases of obesity, today announced IMCIVREE® (setmelanotide) is now available to patients in Germany. IMCIVREE, a melanocortin-4 receptor (MC4R) agonist, last year received marketing authorization from the European Commission for the treatment of obesity and the control of hunger associated with genetically confirmed loss-of-function biallelic pro-opiomelanocortin (POMC), including proprotein convertase subtilisin/kexin type 1 (PCSK1), deficiency or biallelic leptin receptor (LEPR) deficiency in adults and children 6 years old and older. “We are excited to make IMCIVREE available to treat patients in Germany living with the hyperphagia...

Dynacor Declares July 2022 Monthly Dividend

Written by Customer Service on June 22, 2022. Posted in Dividend Reports And Estimates.

MONTREAL, June 22, 2022 (GLOBE NEWSWIRE) — Dynacor Gold Mines Inc. (TSX: DNG) (Dynacor or the Corporation) announced its monthly dividend. The declaration of a dividend payment of C$0.0083 per common share will be payable on July 19, 2022, to shareholders of record as of the close of business on July 8, 2022. This dividend represents the twenty-eight (28th) dividend and (18th) eighteenth monthly payment made to shareholders. The Corporation’s monthly dividend qualifies as an “eligible dividend” for Canadian income tax purposes. The payment and increase of dividends are at the discretion of the Board and will depend on the Corporation’s financial results, cash requirements, prospects and other factors deemed relevant by the Board. ABOUT DYNACOR Dynacor is a dividend-paying industrial gold ore processor headquartered in Montreal,...

First Quarter 2022: Sono Motors Further Accelerates B2B Customer Projects for Solar Integration

Written by Customer Service on June 22, 2022. Posted in Earnings Releases And Operating Results.

Revenues in the First Quarter 2022 Already Exceed Full-Year 2021 Revenues. Revenue Development Fueled by Sono Solar B2B Customer Projects. Solar Business Expansion With 5 New B2B Partnerships in the First Quarter 2022. As of Today, the Sion Series-Validation Vehicle Program Is Picking Up Speed, All Work Streams With New Contract Manufacturer Valmet Automotive Have Been Kicked-off. As of 15 May 2022, Over 18,000 Reservations for the Sion With Average Down Payment of €2,310 Net and Equivalent Net Sales Volume of €393 Million.MUNICH, Germany, June 22, 2022 (GLOBE NEWSWIRE) — Sono Group N.V. (NASDAQ: SEV) (hereafter referred to as “Sono Motors” or the “Company”, parent company to “Sono Motors GmbH”), the company that aims to revolutionize the future of solar-powered transport, today announced its financial results for the first...

OneWater Marine Inc. Signs Definitive Agreement to Acquire Ocean Bio-Chem, Inc.

Written by Customer Service on June 22, 2022. Posted in Mergers And Acquisitions.

Expected to significantly advance growth of parts and accessories business BUFORD, Ga. and FT. LAUDERDALE, Fla., June 22, 2022 (GLOBE NEWSWIRE) — OneWater Marine Inc. (NASDAQ: ONEW) (“OneWater” or the “Company”) announced today that it has signed a definitive agreement to acquire Ocean Bio-Chem, Inc. (NASDAQ: OBCI) (“OBCI” or “Ocean Bio-Chem”), a leading supplier and distributor of appearance, cleaning, and maintenance products for the marine industry and the automotive, powersports, recreational vehicles, and outdoor power equipment markets, for $13.08 per share, in an all-cash transaction valued at approximately $125 million. As part of the transaction, OneWater will also acquire OBCI’s affiliate, Star Brite Europe, Inc. Upon closing of the transaction, both OBCI and Star Brite Europe, Inc. will be integrated into T-H Marine...

Digihost Completes Acquisition of 55 MW Site in Alabama

Written by Customer Service on June 22, 2022. Posted in Mergers And Acquisitions.

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated March 4, 2022 to its short form base shelf prospectus dated February 23, 2022. TORONTO, June 22, 2022 (GLOBE NEWSWIRE) — Digihost Technology Inc. (“Digihost” or the “Company”) (Nasdaq: DGHI; TSXV: DGHI), an innovative U.S. based Bitcoin (“BTC”) mining company, is pleased to announce that it has completed its previously announced transaction with Grede II, LLC to acquire property in the state of Alabama in order to expand the Company’s current operational capacity. The total cash consideration paid for the property by the Company was $1.5 million, with an additional $1.25 million to be paid in 25 equal monthly installments of $50,000 per month. All monetary references in this press release are expressed in USD...

Medicenna Reports Fiscal Year 2022 Financial Results and Operational Highlights

Written by Customer Service on June 22, 2022. Posted in Earnings Releases And Operating Results.

–Cash runway extended late into calendar Q2 2023 –Tumor control achieved following MDNA11 treatment in 3 out of 8 patients enrolled in first 3 dose escalation cohorts of the ABILITY Phase 1/2 Study. — Pharmacodynamic data show superior dose-dependent increase in stimulation of anti-cancer immune cells when compared to competing IL-2 programs in the clinic — Management hosting conference call and webcast today at 8:30 AM ET TORONTO and HOUSTON, June 22, 2022 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA), a clinical stage immunotherapy company, today announced its financial results and operational highlights for the fiscal year ended March 31, 2022. All dollar amounts are expressed in Canadian currency unless otherwise noted. “Over the past fiscal year,...

Winnebago Industries Delivers Record Third Quarter Fiscal 2022 Results

Written by Customer Service on June 22, 2022. Posted in Earnings Releases And Operating Results.

— Record Third Quarter Revenues of $1.5 Billion Increased 52%, Including Robust Organic Growth of 41% — — Reported Quarterly Diluted EPS of $3.57 and Adjusted EPS of $4.13, Up 84% Over Prior Year — — RV Retail Market Share Gains Continue; 13.2%, +70 bps, Fiscal Year-To-Date through April — — Record Share Repurchases of $70 million in the Third Quarter — — $148 million in Cash Returned to Shareholders Through Third Quarter Fiscal Year-To-Date — EDEN PRAIRIE, Minn., June 22, 2022 (GLOBE NEWSWIRE) — Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor lifestyle product manufacturer, today reported financial results for the Company’s Fiscal 2022 third quarter. Third Quarter Fiscal 2022 ResultsRevenues for the Fiscal 2022 third quarter ended May 28, 2022, were a...

uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Written by Customer Service on June 22, 2022. Posted in Public Companies.

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, June 22, 2022 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the Company granted equity awards to 32 newly hired employees as a material inducement to commencing their employment. The equity grants were approved on April 29, 2022 (the “Grant Date”) in accordance with Nasdaq Listing Rule 5635(c)(4). In the aggregate, the employees received 84,900 restricted stock units (“RSUs”) and options to purchase 119,000 ordinary shares of uniQure. Each option has an exercise price of $14.94 per share, the closing price per ordinary share as reported by Nasdaq on the Grant Date. Each option has a ten-year term and will vest over four years from the Grant Date, with 25%...

Cyclacel Pharmaceuticals Announces That Kenneth M. Ferguson, Ph.D. Was Elected to Its Board of Directors

Written by Customer Service on June 22, 2022. Posted in Public Companies.

BERKELEY HEIGHTS, N.J., June 22, 2022 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced the election of Kenneth M. Ferguson, Ph.D., to its Board of Directors. Dr. Ferguson was elected by and will represent the 6% Convertible Exchangeable Preferred stockholders. “We are very pleased to welcome Ken to our Board of Directors,” said Christopher Henney, Ph.D., DSc, Chairman of the Board of Cyclacel. “As a highly accomplished scientist with extensive drug development experience, he will provide significant expertise and insight to help guide our ongoing clinical development programs and advance our company’s pipeline.” “Cyclacel has made tremendous...

OMERS Infrastructure Announces Second Agreement of 2022 to Acquire Australian Digital Infrastructure Assets

Written by Customer Service on June 22, 2022. Posted in Mergers And Acquisitions.

OMERS Infrastructure announces agreement to acquire mobile tower company Stilmark Fourth global investment for OMERS Infrastructure in digital infrastructureSYDNEY, Australia, June 22, 2022 (GLOBE NEWSWIRE) — OMERS Infrastructure today announced that OMERS has signed an agreement to acquire Stilmark, an independent Australian developer, owner and operator of mobile tower assets. The transaction will be OMERS second tower investment in Australia in two months, following the announcement on 9 May that it signed an agreement to acquire 100% of TPG Telecom Limited’s mobile tower and rooftop portfolio. The details of this transaction are not being disclosed. Christopher Curtain, Senior Managing Director, Asia-Pacific for OMERS Infrastructure, said: “We have developed a strong relationship with and respect for the Stilmark management...

Day: June 22, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice